CINCOR PHARMA INC (CINC) Stock Income Statement
USA - NASDAQ:CINC - US17240Y1091 - Common Stock
29.06 USD
-0.14 (-0.48%)
29.25 USD
+0.19 (+0.65%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 82.53M | 42.51M | 21.13M | 5.14M | |||
| Research and Development | 55.94M | 21.51M | 17.95M | 3.93M | |||
| Selling, General, and Administrative Expenses | 26.59M | 21.00M | 3.17M | 1.21M | |||
| Operating Income | -82.53M | -42.51M | -21.13M | -5.14M | |||
| Interest Income/Expense | -5.56M | -7.86M | -1.17M | 101.71K | |||
| Income Before Taxes | -88.09M | -50.37M | -22.30M | -5.04M | |||
| Net Income | -88.09M | -50.37M | -22.30M | -5.04M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -2.38 | -1.38 | -0.61 | -0.14 | |||
| Non GAAP EPS | -17.28 | N/A | N/A | N/A | |||
| Statistics | |||||||
All data in USD